Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?

Bone

Volumn 27, Issue 2, 2000, Pages 177-184

  Nuttall, M E ^a   Gimble, J M ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Zen Bio Inc   (United States)

Author keywords

Adipogenesis; Bone; Differentiation; Osteoblastogenesis; Osteoporosis

Indexed keywords

CELL RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; LEPTIN; LEPTIN RECEPTOR; PARATHYROID HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; DRUG DESIGN; GENE EXPRESSION; HUMAN; IN VITRO STUDY; METABOLIC BONE DISEASE; MORPHOMETRICS; NONHUMAN; OSTEOBLAST; OSTEOPENIA; OSTEOPOROSIS; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TISSUE SPECIFICITY;

ADIPOCYTES; BONE DISEASES, METABOLIC; BONE MARROW CELLS; CELL DIFFERENTIATION; HUMANS; OSTEOBLASTS;

EID: 0033926146     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00317-3     Document Type: Review

References (115)

1. Ailhaud G., Grimaldi P., Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr. 12:1992;207-233.
2. Ashton B.A., Abdullah F., Cave J., Willamson M., Sykes B.C., Couch M., Poser J.W. Characterization of cells with high alkaline phosphatase activity derived from human bone and marrow preliminary assessment of their osteogenicity . Bone. 6:1985;313-319.
3. Bathija A., Davis S., Trubowitz S. Bone marrow adipose tissue response to acute starvation . Am J Hematol. 6:1979;191-198.
4. Bennett J.H., Joyner C.J., Triffitt J.T., Owen M.E. Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci. 99:1991;131-139.
5. Beresford J.N. Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Res. 240:1989;270-280.
6. Beresford J.N., Bennett J.H., Devlin C., Leboy P., Owen M.E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci. 102:1992;341-351.
7. Beresford J.N., Gallagher J.A., Russell R.G.G. 1,25-dihydroxyvitamin D3 and human bone-derived cells in vitro effects on alkaline phosphatase, type I collagen and proliferation . Endocrinology. 119:1986;1776-1785.
8. 3, parathyroid hormone and glucocorticoids. Metab Bone Dis Rel Res. 5:1984;229-234.
9. Bianco P., Riminucci M., Kuznetsov S., Robey P.G. Multipotential cells in the bone marrow stroma regulation in the context of organ physiology . Crit Rev Eukaryotic Gene Expression. 9:1999;159-173.
10. Bianco P., Riminucci M., Majolagbe A., Kuznetsov S.A., Collins M.T., Mankani M.H., Corsi A., Bone H.G., Weintroub S., Spiegel A.M., Fisher L.W., Gehron Robey P. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res. 15:2000;120-128.
11. Birkenmeier E.H., Gwynn B., Howard S., Jerry J., Gordon J.I., Lanschulz W.H., McKnight S.L. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev. 3:1989;1146-1156.
12. Bodine P.V.N., Trailsmith M., Komm B.S. Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res. 11:1996;806-819.
13. Burkhardt R., Kettner G., Bohm W., Schmidmeir M., Schlag R., Frisch B., Mallmann B., Eisenmenger W., Gilg T.H. Changes in trabecular bone, hematopoesis and bone marrow vessels in aplastic anaemia, primary osteoporosis and old age a comparative histomorphometric study . Bone. 8:1987;157-164.
14. Caro J.F., Kolaczynski J.W., Nyce M.R., Ohannesian J.P., Opentanova I., Goldman W.H., Lynn R.B., Zhang P.L., Sinha M.K., Considine R.V. Decreased cerebrospinal-fluid/serum leptin ratio in obesity a possible mechanism for leptin resistance . Lancet. 348:1996;159-161.
15. Chan G.K., Goltzmann D., Karaplis A.C. PTHrP inhibits adipogenesis by downregulating PPARγ activity via MAP kinase signaling. J Bone Miner Res. 14:(Suppl. 1):1999;136.
16. Chawla A., Lazar M.A. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA. 91:1994;1786-1790.
17. Chawla A., Schwartz E.J., Dimaculangan D.D., Lazar M.A. Peroxisome proliferator-activated receptor (PPAR) γ adipose-predominant expression and induction early in adipocyte differentiation . Endocrinology. 135:1994;798-800.
18. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., Rosen V., Mundy G.R., Harris S.E. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol. 142:1998;295-305.
19. Chenu C., Serre C.M., Raynal C., Burt-Pichat B., Delmas P.D. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone. 22:1998;295-299.
20. Christiansen C., Riis B.J., Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet. 1:1987;1105-1108.
21. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 181:1999;67-73.
22. Couse J.F., Korach K.S. Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann Endocrinol (Paris). 60:1999;143-148.
23. Cui Q., Wang G.J., Su C.C., Balian G. The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop. 344:1997;8-19.
24. Custer R.P., Ahlfeldt F.E. Studies on the structure and function of bone marrow. II. Variations in cellularity in various bones with advancing years of life and their relative response to stimuli. J Lab Clin Med. 17:1932;960-962.
25. Dieudonne S.C., Xu T., Chou J.Y., Kuznetsov S.A., Satomura K., Mankani M., Fedarko N.S., Smith E.P., Robey P.G., Young M.F. Immortalization and characterization of bone marrow stromal fibroblasts from a patient with a loss of function mutation in the estrogen receptor-alpha gene. J Bone Miner Res. 13:1998;598-608.
26. Dodds R.A., Gowen M., Bradbeer J.N. Microcytophotometric analysis of human osteoclast metabolism lack of activity in certain oxidative pathways indicates inability to sustain biosynthesis during resorption . J Histochem Cytochem. 42:1994;599-606.
27. Doerrler W., Feingold K.R., Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine. 6:1994;478-484.
28. Doglio A., Dani C., Fredrickson G., Grimaldi P., Ailhaud G. Acute regulation of insulin-like growth factor-1 gene expression by growth hormone during adipose cell differentiation. Eur Mol Biol Organ J. 6:1987;4011-4016.
29. Dorheim M.-A., Sullivan M., Dandapani V., Wu X., Hudson J., Segrani P.R., Rosen D.M., Aulthouse A.L., Gimble J.M. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J Cell Physiol. 154:1993;317-328.
30. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., Shen J., Vinson C., Rueger J.M., Karsenty G. Leptin inhibits bone formation through a hypothalamic relay a central control of bone mass . Cell. 100:2000;197-207.
31. Freytag S.O., Paielli D.L., Gilbert J.D. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8:1994;1654-1663.
32. Friedenstein A.J. Osteogenic stem cells in the bone marrow. Bone Miner Res. 7:1990;243-272.
33. Genever P.G., Bewick G.S., Skerry T.M. Regulated vesicular trafficking in osteoblasts A role in glutamate exocytosis? Bone. 23:(Suppl.):1998;414S.
34. Gimble J.M. The function of adipocytes in the bone marrow stroma. New Biol. 2:1990;304-312.
35. Gimble J.M., Dorheim M.A., Cheng Q., Medina K., Jones R., Koren E., Pietrangeli C., Kincade P.W. Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation biochemical and molecular characterization . Eur J Immunol. 20:1990;379-387.
36. Gimble J.M., Dorheim M.A., Cheng Q., Pekala P., Enerback S., Ellingsworth L., Kincade P.W., Change C.S. Response of bone marrow stromal cells to adipogenic antagonists. Mol Cell Biol. 9:1989;4587-4595.
37. Gimble J.M., Robinson C.E., Wu X., Kelly K.A., Rodriguez B.R., Kliewer S.A., Lehmann J.M., Morris D.C. Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol. 50:1996;1087-1094.
38. Gimble J.M., Youkhana K., Hua X., Bass H., Medina K., Sullivan M., Greenberger J., Wang C.-S. Adipogenesis in a myeloid supporting bone marrow stromal cell line. J Cell Biochem. 50:1992;73-82.
39. Ghosh-Choudhury N., Harris M.A., Wozney J., Mundy G.R., Harris S.E. Clonal osteoblastic cell lines from p53 null mouse calvaria are immortalized and dependent on bone morphogenetic protein 2 for mature osteoblastic phenotype. Biochem Biophys Res Commun. 231:1997;196-202.
40. Ghosh-Choudhury N., Windle J.J., Koop B.A., Harris M.A., Guerrero D.L., Wozney J.M., Mundy G.R., Harris S.E. Immortalized murine osteoblasts derived from BMP-2-T-antigen expressing transgenic mice. Endocrinology. 237:1996;331-339.
41. Green H., Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 5:1975;19-27.
42. Greenberger J.S. Sensitivity of corticosteroid-dependent insulin-resistant lipogenesis in marrow preadipocytes of obese-diabetic (db/db) mice. Nature. 275:1978;752-754.
43. Greenberger J.S. Corticosteroid-dependent differentiation of human preadipocytes in vitro. In-Vitro. 15:1979;823-828.
44. Grigoriadis A.E., Heersche J.N.M., Aubin J.E. Differentiation of muscle, fat, cartilage and bone from progenitor cells present in bone-derived clonal cell populations effect of dexamethasone . J Cell Biol. 106:1988;2139-2151.
45. Grimaldi P.A., Teboul L., Gaillard D., Armengod A.V., Amri E.Z. Long chain fatty acids as modulators of gene transcription in preadipose cells. Mol Cell Biochem. 192:1999;63-68.
46. + fraction of adult human bone marrow contains the osteogenic precursors. Blood. 84:1994;4164-4173.
47. Gundle R., Beresford J.N. The isolation and culture of cells from explants of human trabecular bone. Calcif Tissue Int. 56:1995;8-10.
48. Gundle R., Joyner C.J., Triffitt J.T. Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cells. Bone. 16:1995;597-601.
49. Gundle R., Joyner C., Bradley J., Francis M., Triffitt J., Beresford J.N. Bone formation in vivo by cultured human marrow stromal and trabecular bone-derived cells. Bone. 15:1994;230.
50. Hicok K.C., Thomas T., Gori F., Rickard D.J., Spelsberg T.C., Riggs B.L. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res. 13:1998;205-217.
51. Houghton A., Oyajobi B.O., Foster G.A., Russell R.G., Stringer B.M. Immortalization of human marrow stromal cells by retroviral transduction with a temperature sensitive oncogene identification of bipotential precursor cells capable of directed differentiation to either an osteoblast or adipocyte phenotype . Bone. 22:1998;7-16.
52. Hussain M.M., Mahley R.W., Boyles J.K., Lindquist P.A., Brecht W.J., Innerarity T.L. Chylomicron metabolism chylomicron uptake by bone marrow in different animal species . J Biol Chem. 264:1989;17931-17938.
53. Hu E., Tontonoz P., Spiegelman B.M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARgamma and C/EBP alpha. Proc Natl Acad Sci USA. 92:1995;9856-9860.
54. Ignotz R., Massague J. Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci USA. 82:1985;8530-8534.
55. Jennerman C., Triantafillou J., Cowan D., Pennink B.G.A., Connolly K.M., Morris D.C. Effects of thiazolidinediones on bone turnover in the rat. J Bone Miner Res. 10:(Suppl.):1995;241.
56. Jilka L.R., Weinstein R.S., Takahashi K., Parfitt A.M., Manolagas S.C. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest. 97:1996;1732-1740.
57. Johnson D.C., Collins M.T., Kuznetsov S.A., Majolagbe A., Riminucci M., Bianco P., Robey P.G. Proliferation of human bone marrow stromal cells derived from patients with activating Gs alpha mutations. J Bone Min Res. 14:(Suppl. 1):1999;224.
58. Katzelson L., Finkelstein J.S., Schoenfald D.A., Rosenthal D.I., Anderson E.J., Klibanski A. Increase in bone density and lean body mass during testosterone administration in men by acquired hypogonadism. J Clin Endocrinol Metab. 81:1996;4358-4365.
59. Keen R.W. Effects of lifestyle interventions on bone health. Lancet. 354:1999;1923-1924.
60. 3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinol. 139:1998;2622-2628.
61. Kelly K.A., Tanaka S., Baron R., Gimble J.M. Murine bone marrow stromally derived BMS2 adipocytes support differentiation and function of osteoclast-like cells in vitro. Endocrinology. 139:1998;2092-2101.
62. Kelz M.B., Chen J., Carlezon W.A. Jr, Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature. 401:1999;272-276.
63. Klein K.O., Larmore K.A., de Lancey E., Brown J.M., Considine R.V., Hassink S.G. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab. 63:1998;3469-3475.
64. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., Evans R.M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA. 91:1994;7355-7359.
65. Kodama H.-A., Amagai Y., Koyama H., Kasai S. Hormonal responsiveness of a preadipose cell line derived from newborn mouse calvaria. J Cell Physiol. 112:1982;83-88.
66. Kuznetsov S.A., Krebsbach P.H., Satomura K., Kerr J., Riminucci M., Benayahu D., Robey P.G. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res. 12:1997;1335-1347.
67. Laharrague P., Larrouy D., Fontanilles A.-M., Turel N., Campfield A., Tenenbaum R., Galitzky J., Corberand J.X., Penicaud L., Casteilla L. High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J. 12:1998;747-752.
68. Laketic-Ljubovejic I., Suva L.J., Maathius F.J.M., Sanders D., Skerry T.M. Functional characterization of NMDA-gated channels in bone cells. Bone. 25:1999;631-637.
69. Lecka-Czernik B., Gubrij I., Moerman E.J., Kajkenova O., Lipschitz D.A., Manolagas S.C., Jilka R.C. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cellular Biochem. 74:1999;357-371.
70. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 270:1995;12953-12956.
71. Lian, J. B., Stein, G. S., Canalis, E., Gehron Robey, P., and Boskey, A. L. Bone formation: osteoblast lineage cells, growth factors, matrix proteins and the mineralization process. In: Favus, M. J., Ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 1999.
72. Lin F.T., Lane M.D. CCATT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA. 91:1994;8757-8761.
73. MacDonald B.R., Gallagher J.A., Ahnfelt-Ronne I., Beresford J.N., Gowen M., Russell R.G.G. Effects of bovine parathyroid hormone and 1,25-dihydroxyvitamin D3 on the production of prostaglandins by cells derived from human bone. FEBS Lett. 169:1984;49-52.
74. Martin R.B., Chow B.D., Lucas P.A. Bone marrow fat content in relation to bone remodeling and serum chemistry in intact and ovariectomized dogs. Calcif Tiss Int. 46:1990;189-194.
75. Mason D.J., Suva L.J., Genever P.G., Patton A.J., Stueckle S., Hillam R.A., Skerry T.M. Mechanically regulated expression of a neural glutamate transporter in bone. Role for excitatory amino acids as osteotropic agents? Bone. 20:1997;199-205.
76. Mbalaviele G., Meng A., Jaiswal R., Jaiswal N., Beck S., Pittenger M., Thiede M. Blockade of cytokine-mediated human osteoclastogenesis by activation of peroxisome proliferator-activated receptor-g pathway. J Bone Miner Res. 14:(Suppl.):1999;358.
77. Meunier P.J., Aaron J., Edouard C., Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. Clin Orthop Rel Res. 80:1971;147-154.
78. Mills B.G., Singer F.R., Weiner L.P., Holst P.A. Long-term cultures of cells from bone affected by Paget's disease. Calcif Tissue Int. 29:1979;79-87.
79. Minaire P., Meunier P.J., Edouard C., Bernard J., Courpron J., Bourret J. Quantitative histological data on disuse osteoporosis. Calcif Tiss Res. 17:1974;57-73.
80. Nuttall M.E., Patton A.J., Olivera D.L., Nadeau D.P., Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype implications for osteopenic disorders . J Bone Miner Res. 13:1998;371-382.
81. Okazaki R., Toriumi M., Fukumotot S., Miyamoto M., Fujita T., Tanaka K., Takeuchi Y. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Endocrinology. 140:1999;5060-5065.
82. Owen M. Marrow stromal stem cells. J Cell Sci Suppl. 10:1988;63-76.
83. Oyajobi B.O., Lomri A., Hott M., Marie P.J. Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res. 14:1999;351-361.
84. Park S.R., Oreffo R.O.C., Triffitt J.T. Interconversion potential of cloned human marrow adipocytes in vitro. Bone. 24:1999;549-554.
85. Patton A.J., Genever P.G., Birch M.A., Suva L.J., Skerry T.M. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate receptor signaling pathway in bone. Bone. 22:1998;645-649.
86. Peet N.M., Grabowski P.S., Laketic-Ljubojevic I., Skerry T.M. The glutamate receptor antagonist Mk801 modulates bone resorption in vitro by a mechanism involving osteoclast differentiation. FASEB J. 13:1999;2179-2185.
87. Pietrangeli C.E., Hayashi S.-I., Kinade P.W. Stromal cell lines which support lymphocyte growth characterization, sensitivity to radiation and responsiveness to growth factors . Eur J Immunol. 18:1988;863-872.
88. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science. 284:1999;143-147.
89. Prabhakar U., James I.E., Dodds R.A., Lee-Rykaczewski E., Rieman D.J., Lipshutz D., Trulli S., Jonak Z., Tan K.B., Drake F.H., Gowen M. A novel human bone marrow stroma-derived cell line TF274 is highly osteogenic in vitro and in vivo. Calcif Tissue Int. 63:1998;214-220.
90. Ravn P., Cizza G., Bjarnason N.H., Thompson D., Daley M., Wasnich R.D., McClung M., Hosking D., Yates A.J., Christiansen C. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early postmenopausal intervention cohort (EPIC) study group. J Bone Miner Res. 14:1999;1622-1627.
91. Rickard D.J., Kassem M., Heggeran T.E., Sarkar G., Spelsberg T.C., Riggs B.L. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res. 11:1996;312-324.
92. Riminucci M., Fisher L.W., Majolagbe A., Lala R., Robey P.G., Bianco P. A novel GNAS1 mutation, R201G, in McCune-Albright syndrome (MAS). J Bone Miner Res. 14:(Suppl. 1):1999;S224.
93. Robey P., Termine J. Human bone cells in vitro. Calcif Tiss Int. 37:1985;453-460.
94. Rozman, C., Feliu, E., Berga, L., Reverter, J.-C., Climent, C., and Ferran, M.-J. Age related variations of fat tissue fraction in normal bone marrow depend both on size and number of adipocytes: a stereological study. Exp Hematol 17:43-37; 1989.
95. Sabatakos G., Sims N.A., Chen J.-S., Kelz M., Horne W.C., Nestler E., Baron R. Overexpression of delta-fosB, a splice variant of FosB, promotes osteoblast differentiation at the expense of adipocytes and increases bone formation. J Bone Miner Res. 14:(Suppl. 1):1999;171.
96. Shore E.M., Li M., Hebela N., Jan de Beur S.M., Eddy M.C., Whyte M.P., Levine M.A., Kaplan F.S. Mutations in the gene encoding the stimulatory G protein of adenyl cyclase in progressive osseous heteroplasia (POH). J Bone Miner Res. 14:(Suppl.):1999;342.
97. Sims N.A., Sabatakos G., Chen J.-S., Kelz M., Amling M., Nestler E., Baron R. Progressive and pronounced increase in bone mass, osteosclerosis and reduced adipocytes in mice overexpressing delta-fosB, a truncated form of fosB. J Bone Miner Res. 14:(Suppl. 1):1999;172.
98. Spiegelman B.M. Regulation of gene expression in the adipocyte implications for the obesity and proto-oncogene function . Trends Genetics. 4:1988;203-207.
99. Stein G.S., Lian J.B., Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4:1990;3111-3123.
100. Stevenson J.C., Lees B., Devenport M., Cust M.P., Ganger K.F. Determinants of bone density in normal women risk factors for future osteoporosis . Br Med J. 298:1989;924-928.
101. Student A.K., Hsu R.Y., Lane M.D. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem. 255:1980;4745-4750.
102. Subramaniam M., Colvard D., Keeting P.E., Rasmussen K., Riggs B.L., Spelsberg T.C. Glucocorticoid regulation of alkaline phosphatase, osteocalcin and proto-oncogenes in normal human osteoblast-like cells. J Cell Biochem. 50:1992;411-424.
103. Tavassoli M. Marrow adipose cells and hemopoiesis an interpretive review . Exp Hematol. 12:1984;139-146.
104. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinol. 140:1999;1630-1638.
105. Thompson D.L., Lum K.D., Nygaard S.C., Kuestner R.E., Kelly K.A., Gimble J.M., Moore E.E. The derivation and characterization of stromal cell lines from the bone marrow of p53-/- mice new insights into osteoblast and adipocyte differentiation . J Bone Miner Res. 13:1998;195-204.
106. Tontonoz P., Hu E., Devine J., Beale E.G., Spiegelman B.M. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol. 15:1995;351-357.
107. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B. mPPARγ2; a tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1994;1224-1234.
108. Uchiyama Y., Miyama K., Kataginri T., Yamaguchi A., Takamori H., Nkashima K., Sato T., Suda T. Adipose conversion is accelerated in bone marrow cells of congenitally osteoporotic SAMP6 mice. J Bone Miner Res. 9:(Suppl. 1):1994;365.
109. vanDaele P.L., Stolk R.P., Burger H., Algra D., Grobbee D.E., Hofman A., Birkenhager J.C., Pols H.A. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med. 122:1995;409-414.
110. Wang G.W., Sweet D., Reger S., Thompson R. Fat cell changes as a mechanism of avascular necrosis in the femoral head in cortisone-treated rabbits. J Bone Jt Surg. 59A:1977;729-735.
111. Wang, H. Y., Watkins, D. C., and Malbon, C. C. Antisense oligodeoxynucleotides to GS protein alpha-subunit sequence accelerate differentiation of fibroblasts to adipocytes. Nature 358:334-227; 1992.
112. Weinreb M., Shinar D., Rodan G.A. Different patterns of alkaline phosphatase, osteopontin and osteocalcin expression in developing rat bone by in situ hybridization. J Bone Miner Res. 5:1990;831-842.
113. Wise L.S., Green H. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J Biol Chem. 254:1979;273-275.
114. Wronski T.J., Walsh C.C., Ignaszewski L.A. Histological evidence for osteopenia and increased bone turnover in ovariectomised rats. Bone. 7:1986;119-123.
115. Yamaguchi A., Kahn A.J. Clonal osteogenic cell lines express myogenic and adipocyte developmental potential. Calcif Tissue Int. 49:1991;221-225.